Skip to main content
Monday, November 16, 2026Nov 16

Survey: Business economists see full recovery by end of 2021

A man pushes carts as a hiring sign shows at a Jewel Osco grocery store in Deerfield, Ill., Thursday, April 23, 2020. Friday, Dec. 4, monthly U.S. jobs report will help answer a key question hanging over the economy: Just how much damage is being caused by the resurgent coronavirus, the resulting restrictions on businesses and the reluctance of consumers to shop, travel and dine out? (AP Photo/Nam Y. Huh)
A man pushes carts as a hiring sign shows at a Jewel Osco grocery store in Deerfield, Ill., Thursday, April 23, 2020. Friday, Dec. 4, monthly U.S. jobs report will help answer a key question hanging over the economy: Just how much damage is being caused by the resurgent coronavirus, the resulting restrictions on businesses and the reluctance of consumers to shop, travel and dine out? (AP Photo/Nam Y. Huh)

NEW YORK (AP) – The U.S. economy’s growth is likely slowing as 2020 comes to a close, but a growing number of economists expect it to claw back to its pre-pandemic strength by the second half of next year as vaccines for the coronavirus become widely distributed.

That’s the view from the latest survey of the National Association for Business Economics. It found that 73% of surveyed forecasters say the economy will return to its pre-pandemic level by late 2021. That reflects greater optimism than the forecasters had expressed a couple months ago, when just 38% of them said they thought a full recovery could occur before 2022.

Economists have been saying for months that only when vaccines are widely available to control or defeat the virus will the economy be able to sustain any meaningful recovery from the worst economic downturn since the Great Depression of the 1930s.

Hopes that one or more coronavirus vaccines will roll out soon are helping drive expectations higher, said the survey’s chair, Holly Wade.

“NABE panelists have become more optimistic, on balance,” Wade said, “with nearly one-third revising their outlook higher based on recent news of effective vaccines.”